Has CareDx (CDNA) Outpaced Other Medical Stocks This Year?

Group 1 - CareDx (CDNA) is currently outperforming its Medical sector peers with a year-to-date return of approximately 113.7%, compared to the sector average of 2.1% [4] - The Zacks Rank for CareDx is 2 (Buy), indicating a positive outlook based on earnings estimates and revisions, with a 16.7% increase in the consensus estimate for full-year earnings over the past 90 days [3] - CareDx is part of the Medical Services industry, which has an average year-to-date loss of 5.4%, further highlighting CareDx's strong performance relative to its industry [5] Group 2 - Clover Health Investments, Corp. (CLOV) has also shown strong performance with a year-to-date return of 260.3%, and it holds a Zacks Rank of 2 (Buy) with a 7.7% increase in the consensus EPS estimate over the past three months [4][5] - The Medical sector consists of 1025 individual stocks and currently holds a Zacks Sector Rank of 3, indicating a moderate strength among its groups [2] - The Medical Services industry, which includes CareDx, ranks 138 in the Zacks Industry Rank, while the Medical Info Systems industry, which includes Clover Health, ranks 34 [5][6]